{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,2]],"date-time":"2026-09-02T20:20:36Z","timestamp":1788380436128,"version":"build-2803163510"},"reference-count":33,"publisher":"Springer Science and Business Media LLC","issue":"4","license":[{"start":{"date-parts":[[2016,12,12]],"date-time":"2016-12-12T00:00:00Z","timestamp":1481500800000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/501100000774","name":"Newcastle University","doi-asserted-by":"crossref","id":[{"id":"10.13039\/501100000774","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Graefes Arch Clin Exp Ophthalmol"],"published-print":{"date-parts":[[2017,4]]},"DOI":"10.1007\/s00417-016-3562-0","type":"journal-article","created":{"date-parts":[[2016,12,12]],"date-time":"2016-12-12T03:40:37Z","timestamp":1481514037000},"page":"733-742","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":44,"title":["Vitreoretinal interface abnormalities in patients treatedwith ranibizumab for diabetic macular oedema"],"prefix":"10.1007","volume":"255","author":[{"name":"The Sunderland Eye Infirmary study group","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yun","family":"Wong","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David H. W.","family":"Steel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maged S.","family":"Habib","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alex","family":"Stubbing-Moore","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dalvir","family":"Bajwa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Peter J.","family":"Avery","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2016,12,12]]},"reference":[{"key":"3562_CR1","doi-asserted-by":"crossref","first-page":"1078","DOI":"10.1136\/bjophthalmol-2014-305966","volume":"99","author":"A Khan","year":"2015","unstructured":"Khan A, Mohamed MD, Mann SS, Hysi PG, Laidlaw DA (2015) Prevalence of vitreomacular interface abnormalities on spectral domain optical coherence tomography of patients undergoing macular photocoagulation for centre involving diabetic macular oedema. Br J Ophthalmol 99:1078\u20131081","journal-title":"Br J Ophthalmol"},{"key":"3562_CR2","doi-asserted-by":"crossref","first-page":"1545","DOI":"10.1038\/eye.2010.80","volume":"24","author":"A Ophir","year":"2010","unstructured":"Ophir A, Martinez MR, Mosqueda P, Trevino A (2010) Vitreous traction and epiretinal membranes in diabetic macular oedema using spectral-domain optical coherence tomography. Eye 24:1545\u20131553","journal-title":"Eye"},{"key":"3562_CR3","doi-asserted-by":"crossref","first-page":"883","DOI":"10.1097\/00006982-200510000-00011","volume":"25","author":"D Thomas","year":"2005","unstructured":"Thomas D, Bunce C, Moorman C, Laidlaw AH (2005) Frequency and associations of a taut thickened posterior hyaloid, partial vitreomacular separation and subretinal fluid in patients with diabetic macular edema. Retina 25:883\u2013888","journal-title":"Retina"},{"key":"3562_CR4","doi-asserted-by":"crossref","first-page":"347","DOI":"10.1038\/eye.2009.106","volume":"24","author":"A Ophir","year":"2010","unstructured":"Ophir A, Trevino A, Fatum S (2010) Extrafoveal vitreous traction associated with diabetic diffuse macular oedema. Eye 24:347\u2013353","journal-title":"Eye"},{"key":"3562_CR5","doi-asserted-by":"crossref","first-page":"747","DOI":"10.1016\/j.ajo.2007.07.012","volume":"144","author":"NG Ghazi","year":"2007","unstructured":"Ghazi NG, Ciralsky JB, Shah SM, Campochiaro PA, Haller JA (2007) Optical coherence tomography findings in persistent diabetic macular edema: the vitreomacular interface. Am J Ophthalmol 144:747\u2013754","journal-title":"Am J Ophthalmol"},{"key":"3562_CR6","doi-asserted-by":"crossref","first-page":"44","DOI":"10.1016\/S0002-9394(00)00872-2","volume":"131","author":"PK Kaiser","year":"2001","unstructured":"Kaiser PK, Riemann CD, Sears JE et al (2001) Macular traction detachment and diabetic macular edema associated with posterior hyaloidal traction. Am J Ophthalmol 131:44\u201349","journal-title":"Am J Ophthalmol"},{"key":"3562_CR7","doi-asserted-by":"crossref","first-page":"88","DOI":"10.1159\/000098501","volume":"39","author":"A Gandorfer","year":"2007","unstructured":"Gandorfer A, Rohleder M, Grosselfinger S, Haritoglou C (2007) Diffuse diabetic macular edema: pathology and implications for surgery. Dev Ophthalmol 39:88\u201395","journal-title":"Dev Ophthalmol"},{"key":"3562_CR8","doi-asserted-by":"crossref","first-page":"638","DOI":"10.1016\/j.ajo.2004.11.035","volume":"139","author":"A Gandorfer","year":"2005","unstructured":"Gandorfer A, Rohleder M, Grosselfinger S, Haritoglou C, Ulbig M, Kampik A (2005) Epiretinal pathology of diffuse diabetic macular edema associated with vitreomacular traction. Am J Ophthalmol 139:638\u2013652","journal-title":"Am J Ophthalmol"},{"key":"3562_CR9","doi-asserted-by":"crossref","first-page":"280","DOI":"10.1007\/s10384-012-0130-y","volume":"56","author":"K Tamura","year":"2012","unstructured":"Tamura K, Yokoyama T, Ebihara N, Murakami A (2012) Histopathologic analysis of the internal limiting membrane surgically peeled from eyes with diffuse diabetic macular edema. Jpn J Ophthalmol 56:280\u2013287","journal-title":"Jpn J Ophthalmol"},{"key":"3562_CR10","doi-asserted-by":"crossref","first-page":"753","DOI":"10.1016\/S0161-6420(92)31901-3","volume":"99","author":"H Lewis","year":"1992","unstructured":"Lewis H, Abrams GW, Blumenkranz MS, Campo RV (1992) Vitrectomy for diabetic macular traction and edema associated with posterior hyaloidal traction. Ophthalmology 99:753\u2013759","journal-title":"Ophthalmology"},{"key":"3562_CR11","doi-asserted-by":"crossref","first-page":"146","DOI":"10.3341\/kjo.2007.21.3.146","volume":"21","author":"SJ Song","year":"2007","unstructured":"Song SJ, Sohn JH, Park KH (2007) Evaluation of the efficacy of vitrectomy for persistent diabetic macular edema and associated factors predicting outcome. Korean J Ophthalmol 21:146\u2013150","journal-title":"Korean J Ophthalmol"},{"key":"3562_CR12","doi-asserted-by":"crossref","first-page":"369","DOI":"10.1016\/S0002-9394(01)01050-9","volume":"132","author":"T Yamamoto","year":"2001","unstructured":"Yamamoto T, Akabane N, Takeuchi S (2001) Vitrectomy for diabetic macular edema: the role of posterior vitreous detachment and epimacular membrane. Am J Ophthalmol 132:369\u2013377","journal-title":"Am J Ophthalmol"},{"key":"3562_CR13","doi-asserted-by":"crossref","first-page":"1064","DOI":"10.1016\/j.ophtha.2010.02.031","volume":"117","author":"MJ Elman","year":"2010","unstructured":"Elman MJ, Aiello LP, Beck RW, Bressler NM, Bressler SB, Edwards AR, Ferris FL, Friedman SM, Glassman AR, Miller KM, Scott IU, Stockdale CR, Sun JK (2010) Randomized trial evaluating ranibizumab plus prompt or deferred laser or triamcinolone plus prompt laser for diabetic macular edema. Ophthalmology 117:1064\u20131077","journal-title":"Ophthalmology"},{"key":"3562_CR14","doi-asserted-by":"crossref","first-page":"817","DOI":"10.1007\/s10792-013-9884-6","volume":"34","author":"D Yoon","year":"2014","unstructured":"Yoon D, Rusu I, Barbazetto I (2014) Reduced effect of anti-vascular endothelial growth factor agents on diabetics with vitreomacular interface abnormalities. Int Ophthalmol 34:817\u2013823","journal-title":"Int Ophthalmol"},{"key":"3562_CR15","doi-asserted-by":"crossref","first-page":"587","DOI":"10.1136\/bjophthalmol-2011-301005","volume":"96","author":"RJ Geest Van","year":"2012","unstructured":"Van Geest RJ, Lesnik-Oberstein SY, Tan HS, Mura M, Goldschmeding R, Van Noorden CJ, Klaassen I, Schlingemann RO (2012) A shift in the balance of vascular endothelial growth factor and connective tissue growth factor by bevacizumab causes the angiofibrotic switch in proliferative diabetic retinopathy. Br J Ophthalmol 96:587\u2013590","journal-title":"Br J Ophthalmol"},{"key":"3562_CR16","doi-asserted-by":"crossref","first-page":"1395","DOI":"10.1016\/j.ophtha.2015.02.036","volume":"122","author":"R Sophie","year":"2015","unstructured":"Sophie R, Lu N, Campochiaro PA (2015) Predictors of functional and anatomic outcomes in patients with diabetic macular edema treated with ranibizumab. Ophthalmology 122:1395\u20131401","journal-title":"Ophthalmology"},{"key":"3562_CR17","doi-asserted-by":"crossref","first-page":"1153","DOI":"10.1001\/archophthalmol.2012.1107","volume":"130","author":"SB Bressler","year":"2012","unstructured":"Bressler SB, Qin H, Beck RW, Chalam KV, Kim JE, Melia M, Wells JA (2012) Diabetic Retinopathy Clinical Research Network. Factors associated with changes in visual acuity and central subfield thickness at 1 year after treatment for diabetic macular edema with ranibizumab. Arch Ophthalmol 130:1153\u20131161","journal-title":"Arch Ophthalmol"},{"key":"3562_CR18","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1089\/jop.2011.0070","volume":"28","author":"PC Wu","year":"2012","unstructured":"Wu PC, Lai CH, Chen CL, Kuo CN (2012) Optical coherence tomographic patterns in diabetic macula edema can predict the effects of intravitreal bevacizumab injection as primary treatment. J Ocul Pharmacol Ther 28:59\u201364","journal-title":"J Ocul Pharmacol Ther"},{"key":"3562_CR19","doi-asserted-by":"crossref","first-page":"324","DOI":"10.1016\/j.ophtha.2015.09.032","volume":"123","author":"MA Sadiq","year":"2016","unstructured":"Sadiq MA, Soliman MK, Sarwar S, Agarwal A, Hanout M, Demirel S, Rentiya ZS, Khan W, Do DV, Nguyen QD, Sepah YJ (2016) Effect of vitreomacular adhesion on treatment outcomes in the ranibizumab for edema of the macula in diabetes (READ-3) study. Ophthalmology 123:324\u2013329","journal-title":"Ophthalmology"},{"key":"3562_CR20","doi-asserted-by":"crossref","first-page":"807","DOI":"10.1016\/j.ajo.2004.12.084","volume":"139","author":"D Gaucher","year":"2005","unstructured":"Gaucher D, Tadayoni R, Erginay A, Haouchine B, Gaudric A, Massin P (2005) Optical coherence tomography assessment of the vitreoretinal relationship in diabetic macular edema. Am J Ophthalmol 139:807\u2013813","journal-title":"Am J Ophthalmol"},{"key":"3562_CR21","doi-asserted-by":"crossref","first-page":"1435","DOI":"10.1097\/IAE.0b013e31817f2dae","volume":"28","author":"S Sivaprasad","year":"2008","unstructured":"Sivaprasad S, Ockrim Z, Massaoutis P, Ikeji F, Hykin PG, Gregor ZJ (2008) Posterior hyaloid changes following intravitreal triamcinolone and macular laser for diffuse diabetic macular edema. Retina 28:1435\u20131442","journal-title":"Retina"},{"key":"3562_CR22","doi-asserted-by":"crossref","first-page":"606","DOI":"10.1056\/NEJMoa1110823","volume":"367","author":"P Stalmans","year":"2012","unstructured":"Stalmans P, Benz MS, Gandorfer A, Kampik A, Girach A, Pakola S, Haller JA, MIVI-TRUST Study Group (2012) Enzymatic vitreolysis with ocriplasmin for vitreomacular traction and macular holes. N Engl J Med 367:606\u2013615","journal-title":"N Engl J Med"},{"key":"3562_CR23","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1016\/j.ophtha.2010.04.015","volume":"118","author":"SJ Lee","year":"2011","unstructured":"Lee SJ, Koh HJ (2011) Effects of vitreomacular adhesion on anti-vascular endothelial growth factor treatment for exudative age-related macular degeneration. Ophthalmology 118:101\u2013110","journal-title":"Ophthalmology"},{"key":"3562_CR24","doi-asserted-by":"crossref","first-page":"1757","DOI":"10.1097\/IAE.0000000000000663","volume":"35","author":"SK Houston","year":"2015","unstructured":"Houston SK, Rayess N, Cohen MN, Ho AC, Regillo CD (2015) Influence of vitreomacular interface on anti - vascular endothelial growth factor therapy using treat and extend treatment protocol for age related macular degeneration (Vintrex). Retina 35:1757\u20131764","journal-title":"Retina"},{"key":"3562_CR25","doi-asserted-by":"crossref","first-page":"1203","DOI":"10.1016\/j.ophtha.2015.02.031","volume":"122","author":"TA Ciulla","year":"2015","unstructured":"Ciulla TA, Ying GS, Maguire MG, Martin DF, Jaffe GJ, Grunwald JE, Daniel E, Toth CA (2015) Comparison of Age-Related Macular Degeneration Treatments Trials Research Group. Influence of the vitreomacular interface on treatment outcomes in the comparison of age-related macular degeneration treatments trials. Ophthalmology 122:1203\u20131211","journal-title":"Ophthalmology"},{"key":"3562_CR26","doi-asserted-by":"crossref","first-page":"525","DOI":"10.1007\/s10792-011-9493-1","volume":"31","author":"G Querques","year":"2011","unstructured":"Querques G, Bux AV, Iaculli C, Noci ND (2011) Lamellar macular hole following intravitreal pegaptanib sodium (Macugen) injection for diabetic macular edema. Int Ophthalmol 31:525\u2013527","journal-title":"Int Ophthalmol"},{"key":"3562_CR27","doi-asserted-by":"crossref","first-page":"469","DOI":"10.1177\/112067210801800328","volume":"18","author":"JA Montero","year":"2008","unstructured":"Montero JA, Ruiz-Moreno JM, De La Vega C (2008) Incomplete posterior hyaloid detachment after intravitreal pegaptanib injection in diabetic macular edema. Eur J Ophthalmol 18:469\u2013472","journal-title":"Eur J Ophthalmol"},{"key":"3562_CR28","first-page":"43","volume":"30","author":"FC Erdurman","year":"2012","unstructured":"Erdurman FC, Pellumbi A, Durukan AH (2012) Lamellar macular hole formation in a patient with diabetic CME treated by intravitreal bevacizumab injections. Ophthalmic Surg Lasers Imaging 30:43","journal-title":"Ophthalmic Surg Lasers Imaging"},{"key":"3562_CR29","doi-asserted-by":"crossref","first-page":"213","DOI":"10.1136\/bjo.2007.127142","volume":"92","author":"JF Arevalo","year":"2008","unstructured":"Arevalo JF, Maia M, Flynn HW Jr et al (2008) Tractional retinal detachment following intravitreal bevacizumab (Avastin) in patients with severe proliferative diabetic retinopathy. Br J Ophthalmol 92:213\u2013216","journal-title":"Br J Ophthalmol"},{"key":"3562_CR30","doi-asserted-by":"crossref","first-page":"636","DOI":"10.1016\/j.ophtha.2010.08.038","volume":"118","author":"HA El-Sabagh","year":"2011","unstructured":"El-Sabagh HA, Abdelghaffar W, Labib AM et al (2011) Preoperative intravitreal bevacizumab use as an adjuvant to diabetic vitrectomy: histopathologic findings and clinical implications. Ophthalmology 118:636\u2013641","journal-title":"Ophthalmology"},{"key":"3562_CR31","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1007\/s00417-004-0950-7","volume":"243","author":"H Funatsu","year":"2005","unstructured":"Funatsu H, Yamashita H, Noma H, Mimura T, Nakamura S, Sakata K, Hori S (2005) Aqueous humor levels of cytokines are related to vitreous levels and progression of diabetic retinopathy in diabetic patients. Graefes Arch Clin Exp Ophthalmol 243:3\u20138","journal-title":"Graefes Arch Clin Exp Ophthalmol"},{"key":"3562_CR32","doi-asserted-by":"crossref","first-page":"1480","DOI":"10.1056\/NEJM199412013312203","volume":"331","author":"LP Aiello","year":"1994","unstructured":"Aiello LP, Avery RL, Arrigg PG, Keyt BA, Jampel HD, Shah ST, Pasquale LR, Thieme H, Iwamoto MA, Park JE et al (1994) Vascular endothelial growth factor in ocular fluid of patients with diabetic retinopathy and other retinal disorders. N Engl J Med 331:1480\u20131487","journal-title":"N Engl J Med"},{"key":"3562_CR33","doi-asserted-by":"crossref","unstructured":"Gonzalez VH, Campbell J, Holekamp NM, Kiss S, Loewenstein A, Augustin AJ, Ma J, Ho AC, Patel V, Whitcup SM, Dugel PU (2016) Early and long-term responses to anti-vascular endothelial growth factor therapy in diabetic macular edema: analysis of Protocol I data. Am J Ophthalmol 172:72\u201379","DOI":"10.1016\/j.ajo.2016.09.012"}],"container-title":["Graefe's Archive for Clinical and Experimental Ophthalmology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00417-016-3562-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s00417-016-3562-0\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00417-016-3562-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,9,16]],"date-time":"2019-09-16T08:17:05Z","timestamp":1568621825000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s00417-016-3562-0"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,12,12]]},"references-count":33,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2017,4]]}},"alternative-id":["3562"],"URL":"https:\/\/doi.org\/10.1007\/s00417-016-3562-0","relation":{},"ISSN":["0721-832X","1435-702X"],"issn-type":[{"value":"0721-832X","type":"print"},{"value":"1435-702X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2016,12,12]]}}}